Compare YMAT & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YMAT | HKPD |
|---|---|---|
| Founded | 1970 | 2016 |
| Country | Taiwan | Hong Kong |
| Employees | N/A | 27 |
| Industry | Recreational Games/Products/Toys | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 6.9M |
| IPO Year | N/A | N/A |
| Metric | YMAT | HKPD |
|---|---|---|
| Price | $0.65 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 14.6M | 16.8K |
| Earning Date | 05-13-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.92 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $0.37 |
| 52 Week High | $6.45 | $2.74 |
| Indicator | YMAT | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 80.83 | 41.52 |
| Support Level | $0.32 | $0.37 |
| Resistance Level | $0.68 | $0.71 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 56.19 | 17.19 |
J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.